Brockow K, Ring J
Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein und Zentrum Allergie und Umwelt GSF/TUM, Technische Universität München.
Hautarzt. 2013 Feb;64(2):81-7. doi: 10.1007/s00105-012-2453-5.
Anaphylaxis, the maximal manifestation of an immediate allergic reaction, is a life-threatening systemic reaction. The immediate therapy is chosen according to the clinical manifestations and new German guidelines are in preparation. Required measures include immediate removal of allergen, adequate positioning, assessment of severity and organ involvement and activation of emergency medical services. In anaphylaxis with primarily cardiovascular involvement, epinephrine is the treatment of choice and given together with volume substitution, oxygen, H(1)-antihistamines and corticosteroids. Obstruction of the airways is treated with intramuscular and inhaled epinephrine, or alternatively β(2)-sympathicomimetics, and oxygen. Abdominal or cutaneous involvement, such as generalized urticaria, usually can be treated with intravenous H(1)-antihistamines, glucocorticoids and surveillance. In patients with anaphylaxis, the elicitor of the reaction has to be diagnosed by allergy testing. Patients with sustained risk for anaphylaxis should receive a self-medication kit and should be educated about behavioral patterns needed for prophylaxis and therapy of anaphylactic reactions. Patient educational intervention increases knowledge about anaphylaxis, and practical competence and thus, is a basis of a successful management of anaphylaxis.
过敏反应是速发型过敏反应的最严重表现,是一种危及生命的全身反应。根据临床表现选择即刻治疗方法,德国正在制定新的指南。所需措施包括立即去除过敏原、适当体位、评估严重程度和器官受累情况以及启动紧急医疗服务。对于主要累及心血管系统的过敏反应,肾上腺素是治疗的首选药物,并需同时进行容量替代、吸氧、使用H(1)抗组胺药和糖皮质激素。气道梗阻需使用肌内注射和吸入用肾上腺素治疗,或使用β(2)拟交感神经药和吸氧治疗。腹部或皮肤受累,如全身性荨麻疹,通常可使用静脉注射H(1)抗组胺药、糖皮质激素治疗并进行监测。对于过敏反应患者,必须通过过敏试验诊断反应的诱发因素。有持续过敏反应风险的患者应配备自我给药试剂盒,并应接受关于预防和治疗过敏反应所需行为模式的教育。患者教育干预可增加对过敏反应的了解和实际应对能力,因此是成功管理过敏反应的基础。